Cohort 2 Scholars
Stanford University
School of Medicine
HVTN Site: Duke Human Vaccine Institute
Mentors: Georgia Tomaras and Jonathan Fuchs
Project Title: “Identifying IgG and IgA epitope specificities for gp160 following rAd35 and rAd5 HIV-1 vaccination given as a heterologous prime-boost regimen, or as boosts to a recombinant DNA vaccine in healthy, Ad5-naïve and Ad5- exposed, low risk, HIV-1 uninfected adult participants in HVTN Protocol 077 phase 1b clinical trial”
Meharry Medical College
HVTN Site: Vanderbilt
Mentor: Spyros Kalams
Project Title: “Evaluation of the frequency and phenotype of T follicular helper cells in the peripheral blood of HIV-infected and HIV-negative individuals”
The George Washington
University School of
Medicine
HVTN Site: New York
Mentors: Beryl Koblin and Magda Sobieszczyk
Project Title: “Barriers and Facilitators to HIV Vaccine Trial Participation in a Northern Manhattan Latino Community”
Columbia University
HVTN Site: New York
Mentors: Magda Sobieszczyk and Beryl Koblin
Project Title: “Assessing Providers’ Knowledge of HIV Vaccine Trials and VISP in New York City Clinics”
Mount Sinai School of
Medicine
HVTN Site: Cape Town
Mentors: Magda Sobieszczyk, Linda-Gail Bekker, and Dion Benetatos
Project Title: “Identifying the Barriers for Youth Comprehension of HIV Vaccine Trial Consent Process”
Georgia Health Sciences
University
HVTN Site: Atlanta
Mentors: Mark Mulligan and Julia Painter
Project Title: “Investigating the Motivators and Barriers to Recruitment and Retention of African Americans in Atlanta-based HIV Vaccine Trials”
Keck School of Medicine of
the University of Southern
California
HVTN Site: Lima
Mentors: Jorge Sanchez, Patricia Segura, and Jonathan Fuchs
Project Title: “Short Message Services as an HIV Vaccine Recruitment Technique”